In IDH‐mutated AML, 2HG activates the NFκB pathway in BM stromal cells, leading to the production of cytokines, including IL‐6, IL‐8, and complement 5a, which might stimulate the progression of AML [50]. The gene discussed is IDH1; the disease is acute myeloid leukemia.